Camber Spine Announces 1Q19 Sales Results +22% vs. 1Q18

Camber Spine announced 1Q19 preliminary proprietary sales results of +22% vs. 1Q18. (Proprietary sales refers to products innovated and owned by the company.)

Growth was largely driven by continuing adoption of SPIRA and ENZA products, which grew +97% vs. the prior year. The company has plans to launch a device for sacroiliac joint...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us